|
Mar 13
|
Cellectis Reports Financial Results for the Fourth Quarter and Full Year 2024 and Provides a Business Update
|
|
Feb 24
|
Cellectis Presents ‘Smart CAR T’ Strategy to Enhance Efficacy Against Solid Tumors at AACR-IO 2025
|
|
Jan 8
|
Monthly information on share capital and company voting rights
|